https://www.selleckchem.com/products/prt4165.html
Seventeen of the 59 patients survived at last follow-up. Patients60years had a greater 3-year OS compared with patients≥60years (52.6% [33.6%-71.6%] vs 13.9% [1.4%-26.4%]. Multivariate analysis has demonstrated that only age at diagnosis (≥60/60years) exhibited a significant relationship with OS (HR, 3.495 [1.688-7.235];p=0.001). Sex (female/male) was observed to have a doubted trend towards significance (HR, 0.487 [0.231-1.030]; p=0.06. PCNSTCL is generally of poor prognosis but younger age at diagnosis (60years) predicts
Like
Comment
Share
